Biogen INC DEF 14A proxy statements

Biogen Inc. filed its 2026 Proxy Statement detailing director nominations, executive compensation, and corporate governance practices, with an annual meeting scheduled for June 9, 2026.

Biogen Inc. outlines its multi-year transformation strategy, highlights 2024 achievements including new product launches and cost savings, and details its pay-for-performance executive compensation structure ahead of its June 17, 2025 annual meeting.

Biogen Inc. announces its 2025 Annual Meeting and provides information on how stockholders can access proxy materials and vote.

Biogen's 2025 proxy statement outlines key governance practices, executive compensation aligned with long-term stockholder value, and commitment to corporate responsibility.

Biogen Inc. announces its 2024 Annual Meeting of Stockholders to be held on June 20, 2024, featuring proposals including the election of directors, ratification of the company's accounting firm, executive compensation, and approval of amendments to the company's certificate of incorporation and stock purchase plan.

Biogen is asking stockholders to vote on key proposals including officer exculpation, equity incentive plans, and director elections at its upcoming annual meeting.